Welcome to Pedagogy   |   Sign In


Cannabidiol (CBD) is currently available in the fields of food and beverages, cosmetics, and pharmaceuticals.  With respect to this growing industry and its consumer usage, healthcare providers need to be educated on various issues relevant to the medicolegal aspects of CBD usage.

CBD is one of more than 80 active compounds called cannabinoids found naturally in the cannabis sativa plant. Extracting it results in a thick oily paste, which is then typically mixed with a carrier oil, such as hemp oil or coconut oil, to produce a product with a specific concentration of CBD. That product is termed CBD oil. This form of CBD has many routes of administration, including ingestion (gummy candies, coffee, capsules and drops);  inhalation (adding  the oil to e-cigarettes) , topically ( as in creams and salves) and sublingual ( drops placed under the tongue). Considering the half-life of CBD is from 18-32 hours, this oil has been viewed favorably in the medical community.

The Food and Drug Administration has approved Epidiolex for the treatment of some rare seizure syndromes. In addition, many countries are participating in CBD research to treat conditions involving various neurological, neuromuscular, and psychological disorders. 

For more information on this exciting field of research, including information on the Farm Hemp Bill, the Medical Marijuana Compassion Act and the American Cannabis Nurses Association Click Here

For nurses and other healthcare professionals wanting to learn more about CBD, consider taking our CBD 101: An Introductory Course

CBD (in the form of oils, creams, lotions, edibles and more) has entered mainstream America! Their presence has been noted in the fields of food and beverages, cosmetics, and pharmaceuticals. With projections for this industry to surpass $20 billion dollars by the year 2024, healthcare providers need to be aware of the ever-growing consumer usage, as well as the medical and legal implications for its users.

CBD is defined as cannabidiol. It is an active chemical in the Cannabis Sativa plant (also known as marijuana or hemp). While CBD is one of over 80 chemicals (known as cannabinoids), by itself it does not cause a “high”. According to the World Health Organization, CBD exhibits no effects indicative of any abuse or dependence potential. Furthermore, to date, there is no evidence of public health-related problems associated with the use of pure CBD. The issue at hand is actually the origin of the CBD ingredients. While delta-9-tetrahydrocannabinol (THC) is the major active ingredient in marijuana, cannabidiol is also obtained from hemp, which contains only very small amounts of THC.


The purpose of the continuing education program is to inform and educate healthcare providers on the various forms of CBD and their usage in mainstream medicine. Upon completion of this course participants will be able to:
  1. Discuss the origins of CBD usage.
  2. Verbalize differences between marijuana-based and hemp-based CBD products.
  3. Identify recognized usages for CBD (disease-specific).
  4. Discuss route of administration for CBD usage.
  5. Discuss components of the farming hemp bill.
  6. Verbalize federal laws related to CBD usage (healthcare workers and urine drugs screens).
  7. Discuss medical marijuana act/medical compassion act.
  8. Identify state rules regarding CBD.
  9. Acknowledge the need for additional research to identify CBD based products that offer optimal benefit with minimal risk.

Chapter 1: Introduction

Chapter 2: History

Chapter 3: The Endocannabinoid System

Chapter 4: CBD Availabel Routes Of Administration
  • Ingested
  • Sublingual
  • Topical
  • Inhaled
Chapter 5: CBD And Medical Treatments (Condition Specific)
  • Insufficient Evidence
Chapter 6: CBD And Known Side Effects
  • The Entourage Effect
Posted: 12/15/2019 12:39:25 PM
Blog post currently doesn't have any comments.
Leave comment

 Security code
Copyright © 2020 Pedagogy, Inc. All Rights Reserved.

Powered by Kentico